Monday June 26th 2017

Posts Tagged ‘national’

Medicare Advantage plan members may switch to Original Medicare during the annual disenrollment period Jan 1 to Feb 14

Medicare Advantage plan members may switch to Original Medicare during the annual disenrollment period Jan 1 to Feb 14

Recent changes to the provider networks of certain Medicare Advantage plans (private Medicare managed care plans) are reported to be causing concern within the MS community. Medicare Advantage (MA) plan members are reminded that they have options if they are dissatisfied [Read More]

Trainees in MS Research and Clinical Care Connect at the 2013 Tykeson Fellows Conference

Trainees in MS Research and Clinical Care Connect at the 2013 Tykeson Fellows Conference

The 4th Tykeson Fellows Conference on MS brought nearly 100 young National MS Society and MS International Federation research and clinical fellows together with senior scientists to learn about each other’s latest research efforts, as well as interact with the attendees [Read More]

Letter to Budget Conferees Urges Protection of Research and Programs Important to People with MS

Letter to Budget Conferees Urges Protection of Research and Programs Important to People with MS

Society urges budget conferees to protect research and programs needed by people living with MS. [Read More]

 Page 1 of 2  1  2 »

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]